By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LEO Pharma 

Industriparken 55
DK-2750 Ballerup
Copenhagen      Denmark
Phone: 45-4492-3800 Fax: 45-4494-3040



Company News
MorphoSys AG And LEO Pharma Enter Into Strategic Alliance To Develop Therapeutic Antibodies In Dermatology 11/2/2016 1:26:53 PM
Denmark's LEO Pharma Opens Up Shop in Cambridge 9/30/2016 5:58:00 AM
AstraZeneca PLC (AZN), Valeant (VRX) and LEO Pharma Shuffle Dermatology Rights, Potential $1 Billion in Sales at Stake 7/1/2016 7:41:25 AM
LEO Pharma to Pay AstraZeneca PLC (AZN) $115 Million Upfront and $1 Billion in Milestones for Two Dermatology Drug Rights 7/1/2016 6:06:36 AM
American Skin Association Announces New Board Of Directors Members Gitte Aabo Of LEO Pharma And Dr. George Cotsarelis Of Penn Medicine 4/25/2016 6:52:03 AM
LEO Pharma Receives Scientific Approval Of Enstilar For The Treatment Of Psoriasis In EU 3/21/2016 6:06:06 AM
arGEN-X Receives Milestone Payment In LEO Pharma Collaboration 2/2/2016 9:10:02 AM
LEO Pharma Puts Up €675 Million for Astellas (ALPMY)'s Global Dermatology Biz 11/11/2015 6:13:07 AM
LEO Pharma Announces FDA Approval Of Enstilar(Calcipotriene And Betamethasone Dipropionate) Foam, 0.005%/0.064% For Plaque Psoriasis 10/19/2015 7:58:47 AM
LEO Pharma Release: New Study Investigating The Effect Of Low-Molecular-Weight Heparins On The Treatment Of Blood Clots In Cancer Patients 8/19/2015 6:49:48 AM